About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2024
2023
2022
2021
2020
2019
26
Aug 2021
14:38 E.S.T.
Cellectis Announces Participation in Five Investor Conferences
Read more
05
Aug 2021
14:43 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for Second Quarter and First Six Months 2021
Read more
29
Jul 2021
16:06 E.S.T.
Cellectis to Hold Second Quarter 2021 Earnings Call on Friday, August 6, 2021 at 8AM EDT
Read more
14
Jun 2021
14:11 E.S.T.
Cellectis’ Innovation Days event highlighted New Product Development, New Genome Surgery Platform .HEAL, and Manufacturing Capabilities
Read more
02
Jun 2021
02:35 E.S.T.
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021
Read more
11
May 2021
13:05 E.S.T.
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
Read more
Prev
17
18
19
20
21
Next